Annexin A1 as a potential prognostic biomarker for COVID‐19 disease: Case–control study
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of Clinical Practice"
DOI: 10.1111/ijcp.14606
Abstract: Annexin A1 (AnxA1) is an important endogenous glucocoticoid protein that contributes to the suppression of inflammation by limiting the production of neutrophil and pro‐inflammatory cytokines. This study aims to determine the clinical predictivity value of… read more here.
Keywords: biomarker covid; study; potential prognostic; annexin potential ... See more keywords